RCH-ACV

Information for RCH-ACV

Description

Human B cell precursor leukemia cell line; established from bone marrow cells taken at relapse of common acute lymphoblastic leukemia (cALL), seven months after diagnosis, from an 8-year-old girl treated with combination chemotherapy.

Source BRENDA Tissue Ontology (BTO)

ReMap Statistics

Datasets
3
Transcriptional Factors
3
Peaks
135,864
Non-redundant peaks
86,899

Description

Cell_name
RCH-ACV
Category
Cancer cell line
Disease
NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
Sex_gender_of_cell
Female
Age_of_donor
8Y

External IDs

Cellosaurus
CVCL_1851
Experimental Factor
BRENDA Tissue
BTO:0003376
Wiki
RCH-ACV
ATCC
RCH-ACV
Synonyms
RCH; RCHACV
All peaks RCH-ACV
Download BED file
Non redundant RCH-ACV
Download BED file
CRMs RCH-ACV
Download BED file
DOWNLOAD All ReMap
Go to catalogue

Datasets Table for RCH-ACV

Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks
RCH-ACV KMT2A GEO Homo sapiens GSE83671 Download (52,056)
RCH-ACV PBX1 GEO Homo sapiens GSE85988 Download (33,611)
RCH-ACV TCF3 GEO Homo sapiens GSE85988 Download (50,197)
Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.